RxDoctor Payments Data

Alan Valente Padua, MD

Family Medicine · Saint Louis, MONPI 1023218757

Payments from drug & device makers

$4,121in general payments, 2019–2025

Across 242 payments — averaging $17.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$740
  • AstraZeneca$640
  • Lilly USA, LLC$575
  • Pfizer$382
  • GSK$326
  • Novo Nordisk$325
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$4,104100%
  • Entertainment$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,121 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$159,476
Medicare patients
965
Services billed
8,567

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide78$75,158
EliquisApixaban61$62,107
JardianceEmpagliflozin42$42,607
Semglee (Yfgn) PenInsulin Glargine-Yfgn78$39,784
ArexvyRsvpref3 Antigen/As01e/Pf137$36,723
MounjaroTirzepatide33$34,132
TrulicityDulaglutide23$23,590
ProliaDenosumab12$20,084
XareltoRivaroxaban18$18,409
Repatha SureclickEvolocumab25$18,023
AbrysvoRsv Vacc, Pref A And Pref B/Pf45$13,304
Dabigatran EtexilateDabigatran Etexilate Mesylate29$12,177
Breo ElliptaFluticasone/Vilanterol17$9,083
Atorvastatin Calcium528$5,213
ShingrixVaricella-Zoster Ge/As01b/Pf25$4,990

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$382$75,411106 claims
Novo NordiskOzempic$325$75,15878 claims
Lilly USA, LLCMounjaro, Trulicity$575$57,72356 claims
GSKArexvy, Breo Ellipta, Shingrix$326$50,796179 claims
Boehringer IngelheimJardiance$28$42,60742 claims
AmgenProlia$192$20,08412 claims
Johnson & JohnsonXarelto$153$18,40918 claims
AbbVieSynthroid$740$1,69329 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →